Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Gene-editing summit supports some research in human embryos

Nature (2015)Cite this article

Subjects

Three-day meeting calls for further discussions on modifications to the gene pool.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Sara Reardon
    View author publications

    You can also search for this author inPubMed Google Scholar

Additional information

Tweet Follow @NatureNews

Related links

Related links

Related links in Nature Research

Perspective: Embryo editing needs scrutiny 2015-Dec-02

Human-genome editing summit to sample global attitudes 2015-Nov-30

Genome editing: 7 facts about a revolutionary technology 2015-Nov-30

CRISPR: A path through the thicket 2015-Nov-10

CRISPR: the good, the bad and the unknown

Related external links

National Academies Human Gene Editing Initiative

Doudna lab

George Church

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reardon, S. Gene-editing summit supports some research in human embryos. Nature (2015). https://doi.org/10.1038/nature.2015.18947

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nature.2015.18947

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research